montelukast FDA Link

a leukotriene D4 receptor antagonist

Also Known As:

Singulair; 1- ((((1R)- 1- (3- ((E)- 2- (7- chloro- 2- quinolinyl)ethenyl)phenyl)- 3- (2- (1- hydroxy- 1- methylethyl)phenyl)propyl)thio)methyl)- cyclopropaneacetic acid; MK 0476; MK-0476; montelukast sodium; sodium 1- (((1- (3- (2- (7- chloro- 2- quinolinyl)ethenyl)phenyl)- 3- (2- (1- hydroxy- 1- methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate

Pharmalogical Action Categories:

D018927 - Anti-Asthmatic Agents
D020024 - Leukotriene Antagonists
D065694 - Cytochrome P-450 CYP1A2 Inducers

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Cyclopropanes: 9
        montelukast: 1658
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acetates: 4994
      - montelukast: 1658
- Sulfur Compounds: 278
  - Sulfides: 1062
    - montelukast: 1658
Lipids: 114793
- Fatty Acids: 27405
  - Volatile Fatty Acids: 3052
    - Acetates: 4994
      - montelukast: 1658
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - montelukast: 1658
Inorganic Chemicals: 9
- Electrolytes: 16106
  - Ions: 7857
    - Anions: 3501
      - Sulfides: 1062
        montelukast: 1658
- Sulfur Compounds: 278
  - Hydrogen Sulfide: 2764
    - Sulfides: 1062
      - montelukast: 1658

Yoko Terasawa Selected Research

Yoko Terasawa Research Topics

Disease

Drug/Important Bio-Agent (IBA)